TSTickerStarGet alerts

BYND 10-Q filed 2026-11-10 | Key takeaways

BYND filed its 10-Q; the most relevant disclosure change is added Reverse stock split: The company effected a 1-for-30 reverse stock split of its common stock effective August 13, 2026, reducing authorized shares from 3,000,000,000 to 100,000,000 and resulting in 18,755,734 shares outstanding as of November 6, 2026. Customer concentration: Distributor One represented 14% of revenue; Distributor Two represented 12% of revenue.

Share this story

Key takeaways

  • Impairment: $57.1 million total loss from impairment recognized in Q3 2026 ($27.3M entity-wide + $29.8M sublease asset group) versus $51.3 million in Q3 2025

  • Reverse split: 1-for-30 reverse stock split effective August 13, 2026 reduced authorized shares from 3 billion to 100 million; shares outstanding as of November 6, 2026 were 18,755,734

  • Debt exchange: On September 23, 2026, the company exchanged $15 million of 2027 Notes for 1,097,444 shares of common stock (with additional 455,184 shares delivered September 28, 2026); remaining 2027 Notes outstanding were $14.5 million as of September 26, 2026

  • Campus lease: Fifth Amendment executed July 31, 2026 surrendered approximately 101,612 rentable square feet of Campus Headquarters with $14 million compromise rent payable over 48 months and restoration obligations costing approximately $4.9 million

  • Prior period correction: Errors identified in Q1-Q3 2025 financial statements related to inventory valuation, debt issuance costs, and impairment, with corrections reflected in comparative periods

  • Customer concentration: Two distributors accounted for approximately 14% and 12% of gross revenues in Q3 2026, versus approximately 13% and 11% in Q3 2025

Key metrics

Total net revenues - Q3Q3 2026
$64.5 million-8.1%
Total net revenues - YTDNine months 2026
$191.6 million-10.4%
Net loss - Q3Q3 2026
$(82.8) millionimproved from $(97.0)M
Net loss - YTDNine months 2026
$(94.9) millionimproved from $(189.9)M
Net loss per diluted share - Q3Q3 2026
$(4.32)improved from $(37.96)
U.S. net revenues - Q3Q3 2026
$34.3 million-12.3%
International net revenues - Q3Q3 2026
$30.3 million-2.8%
Loss from impairment - Q3Q3 2026
$57.1 million$5.8M increase

Customer concentration

Distributor OneQ3 2026
14%Share of revenue
Distributor TwoQ3 2026
12%Share of revenue

Disclosure changes

  • Reverse stock split

    The company effected a 1-for-30 reverse stock split of its common stock effective August 13, 2026, reducing authorized shares from 3,000,000,000 to 100,000,000 and resulting in 18,755,734 shares outstanding as of November 6, 2026.

    The reverse split significantly reduced share count and affected all per-share metrics and conversion ratios for outstanding notes and warrants
  • 2027 Notes exchange

    On September 23, 2026, the company exchanged $15 million of 2027 Notes at 96% of face value for 1,097,444 shares of common stock, with additional 455,184 shares delivered September 28, 2026; $14.5 million in 2027 Notes remained outstanding.

    This transaction reduces debt outstanding and results in dilution to existing shareholders; accounted for as troubled debt restructuring
  • Campus lease amendment

    Fifth Amendment to Campus Lease executed July 31, 2026 surrendered approximately 101,612 rentable square feet, required $14 million compromise rent over 48 months, and estimated $4.9 million in restoration costs; remaining premises of approximately 118,907 square feet continue to be leased.

    The lease amendment reduces the company's real estate footprint and future lease obligations but requires significant near-term cash payments and restoration costs
  • Impairment of long-lived assets

    Q3 2026 total impairment of $57.1 million comprising $27.3 million entity-wide asset group impairment and $29.8 million sublease asset group impairment; triggered by significant decline in market capitalization and change in asset use.

    Continued impairment charges reflect ongoing challenges in the plant-based meat category and declining company market value
  • Prior period error correction

    The company corrected errors in previously issued Q1-Q3 2025 interim financial statements related to inventory valuation ($8.5M overstatement), debt issuance costs ($14.1M understatement of expenses), and impairment calculation ($26.1M overstatement of loss).

    Prior period comparisons have been restated, affecting previously reported gross profit, SG&A, net loss, and per-share metrics
  • 2030 Notes Embedded Derivative

    The 2030 Notes Embedded Derivative liability decreased to $1.3 million as of September 26, 2026 from $39.2 million as of December 31, 2025, due to conversions and fair value remeasurement gains of $21.4 million in nine months 2026.

    Significant reduction in derivative liability reflects both conversions of notes to equity and favorable fair value adjustments

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow BYND in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert